Pfizer Loses Norvasc Ruling: Rx Patent Extensions Are For Product, Not Use

A drug's patent term extension applies only to the FDA-approved product, not the active moiety's use, Newark federal court Judge Katharine Hayden ruled in Pfizer v. Dr. Reddy's

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet